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ABSTRACT 
Antipsychotics are well known to affect prolactin secretion, resulting in hyperprolactinemia and its consequent manifestations like amenorrhoea, 
galactorrhoea, gynaecomastia, etc. Levosulpiride is a novel antipsychotic drug with additional antidepressant, antiemetic and antidyspeptic actions. 
The authors report a case of levosulpiride-induced hyperprolactinemia, presenting as galactorrhoea in a female patient with dyspepsia at Kasturba 
Hospital, Manipal, in South India. 
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INTRODUCTION 
Levosulpiride is the levorotatory enantiomer of sulpiride, a 
substituted benzamide. Chemically, it is N-[(1-ethylpyrrolidin-2-yl) 
methyl]-2-methoxy-5-sulfamoyl-benzamide. The drug is being used 
as an antipsychotic, an antidepressant, an antiemetic and an 
antidyspeptic [1]. It may also find use in the treatment of 
somatoform disorders, premature ejaculation, burning mouth 
syndrome, etc [2, 3]. The main mechanism of antipsychotic action of 
levosulpiride is blockade of the D2 dopaminergic receptors, 
preferentially located on the presynaptic membranes in the 
dopaminergic pathways of the brain. In the GIT, the drug acts by 
blocking enteric inhibitory dopaminergic D2
As with other typical (1
 receptors [1]. 
st
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 generation) antipsychotics, levosulpiride 
can also block the dopaminergic receptors, which are normally 
inhibitory in nature with respect to prolactin release [4]. Thus, 
prolactin secretion is increased, resulting in hyperprolactinemia, 
although there are no reports available in the current Indian 
literature, to the best of our knowledge. We present a case of 
levosulpiride-induced galactorrhoea, secondary to hyperpro-
lactinemia. This report has been written after obtaining consent 
from the patient. 
A 52-year-old year female came to Kasturba Hospital, Manipal, with 
history of galactorrhoea for the past 15 d. On further elicitation of 
her recent medical history, it was found that she was suffering from 
dyspeptic symptoms, for which she had been prescribed oral 
levosulpiride. She was on this medication for the past 3 w. There was 
no history of headache or visual disturbances. On general 
examination, her vital signs were stable. Local causes of 
galactorrhoea were ruled out. The patient’s systemic examination 
was within normal limits. 
Routine laboratory investigations, including a complete 
haemogram, renal and liver function tests were all within normal 
limits. An MRI of the brain was done, which came out to be normal. 
A hormonal assay was done, which revealed a serum prolactin 
value of 202 ng/ml (which was high; normal levels being between 
2 to 29 ng/ml for a non-pregnant female), TSH of 1.810 mcU/ml 
(which was within the normal range), LH of 5 mIU/ml (which was 
normal) and FSH of 7.2 mIU/ml (which was also normal). 
Since local and central causes of hyperprolactinemia were ruled out, 
a diagnosis of levosulpiride-induced galactorrhoea was arrived at, 
based on the existing data on the adverse effect profile of 
antipsychotic medication.  
Following this, the patient was taken off levosulpiride therapy. On 
the next follow-up visit, the patient was symptomatically better, and 
her prolactin level was also found to be within normal limits. 
DISCUSSION 
In patients with functional dyspepsia, levosulpiride is found to be 
effective, as evidenced in the present case. In addition to the 
dopaminergic blockade, the role of 5HT4
But, there are not many reports on the drug’s ability to cause 
disturbances in the secretion of prolactin.  
 receptor stimulation has 
also been postulated for the drug’s efficacy as a prokinetic drug [1]. 
Levosulpiride is well known to cause movement disorders de 
dopaminergic inhibition in the nigrostriatal pathway, resulting in 
Parkinson-like features, acute dystonias, Rabbit syndrome, 
akathesia, etc [5].  
However, as with other similar drugs, hyperprolactinemia, in this 
case, is expected to be secondary to dopaminergic inhibition, 
resulting in galactorrhoea and amenorrhoea, as reported in a few 
clinical trials [6]. The general consensus for management of such 
cases is discontinuation of the drug, as was done in our patient as 
well, which led to relief of symptoms and normalization of 
prolactin levels. 
CONCLUSION 
To conclude, any patient who presents with galactorrhoea 
should be asked about history of use of antipsychotic 
medication, although the use of such drugs may not be solely for 
their antipsychotic property. As seen in this case, the patient was 
prescribed levosulpiride, not for the antipsychotic indication, 
but for dyspepsia. Hence, drug-induced hyperprolactinemia 
should be kept in mind when arriving at differential diagnoses in 
such cases. 
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